ID   NOLC1_RAT               Reviewed;         704 AA.
AC   P41777; F1LPS3;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2017, sequence version 2.
DT   24-JUL-2024, entry version 165.
DE   RecName: Full=Nucleolar and coiled-body phosphoprotein 1 {ECO:0000305};
DE   AltName: Full=140 kDa nucleolar phosphoprotein {ECO:0000303|PubMed:1623516};
DE            Short=Nopp140 {ECO:0000303|PubMed:1623516};
DE   AltName: Full=Nucleolar 130 kDa protein;
DE   AltName: Full=Nucleolar phosphoprotein p130;
GN   Name=Nolc1 {ECO:0000312|RGD:621578};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 292-309 AND 563-601,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RC   TISSUE=Liver;
RX   PubMed=1623516; DOI=10.1016/0092-8674(92)90539-o;
RA   Meier U.T., Blobel G.;
RT   "Nopp140 shuttles on tracks between nucleolus and cytoplasm.";
RL   Cell 70:127-138(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND IDENTIFICATION.
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   INTERACTION WITH NOP58, AND FIBRILLARIN.
RX   PubMed=10679015; DOI=10.1091/mbc.11.2.567;
RA   Yang Y., Isaac C., Wang C., Dragon F., Pogacic V., Meier U.T.;
RT   "Conserved composition of mammalian box H/ACA and box C/D small nucleolar
RT   ribonucleoprotein particles and their interaction with the common factor
RT   Nopp140.";
RL   Mol. Biol. Cell 11:567-577(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567 AND SER-703, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Nucleolar protein that acts as a regulator of RNA polymerase
CC       I by connecting RNA polymerase I with enzymes responsible for ribosomal
CC       processing and modification. Required for neural crest specification:
CC       following monoubiquitination by the BCR(KBTBD8) complex, associates
CC       with TCOF1 and acts as a platform to connect RNA polymerase I with
CC       enzymes responsible for ribosomal processing and modification, leading
CC       to remodel the translational program of differentiating cells in favor
CC       of neural crest specification. Involved in nucleologenesis, possibly by
CC       playing a role in the maintenance of the fundamental structure of the
CC       fibrillar center and dense fibrillar component in the nucleolus. It has
CC       intrinsic GTPase and ATPase activities. {ECO:0000250|UniProtKB:Q14978}.
CC   -!- SUBUNIT: Interacts with RNA polymerase I 194 kDa subunit (RPA194) and
CC       with casein kinase-II (By similarity). Interacts with DKC1/NAP57, NOP58
CC       and fibrillarin (PubMed:10679015). {ECO:0000250|UniProtKB:Q14978,
CC       ECO:0000269|PubMed:10679015}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1623516}. Nucleus,
CC       nucleolus {ECO:0000269|PubMed:1623516}. Note=Shuttles on curvilinear
CC       tracks between nucleolus and cytoplasm. These tracks extend from the
CC       dense fibrillar component of the nucleolus across the nucleoplasm to a
CC       limited number of nuclear pore complexes. {ECO:0000269|PubMed:1623516}.
CC   -!- PTM: Undergoes rapid and massive phosphorylation/dephosphorylation
CC       cycles on CK2 and PKC sites. NOLC1 is one of the mostly phosphorylated
CC       proteins in the cell. {ECO:0000269|PubMed:1623516}.
CC   -!- PTM: Ubiquitinated. Monoubiquitination by the BCR(KBTBD8) complex
CC       promotes the formation of a NOLC1-TCOF1 complex that acts as a platform
CC       to connect RNA polymerase I with enzymes responsible for ribosomal
CC       processing and modification, leading to remodel the translational
CC       program of differentiating cells in favor of neural crest
CC       specification. {ECO:0000250|UniProtKB:Q14978}.
CC   -!- PTM: Pyrophosphorylated by 5-diphosphoinositol pentakisphosphate (5-
CC       IP7). Serine pyrophosphorylation is achieved by Mg(2+)-dependent, but
CC       enzyme independent transfer of a beta-phosphate from a inositol
CC       pyrophosphate to a pre-phosphorylated serine residue.
CC       {ECO:0000250|UniProtKB:E9Q5C9}.
CC   -!- SIMILARITY: Belongs to the NOLC1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94287; AAA41718.1; -; mRNA.
DR   EMBL; M94288; AAA41719.1; -; mRNA.
DR   EMBL; AC119478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; B42680; B42680.
DR   RefSeq; NP_074060.1; NM_022869.1.
DR   AlphaFoldDB; P41777; -.
DR   SMR; P41777; -.
DR   BioGRID; 249215; 2.
DR   IntAct; P41777; 2.
DR   STRING; 10116.ENSRNOP00000025788; -.
DR   iPTMnet; P41777; -.
DR   PhosphoSitePlus; P41777; -.
DR   jPOST; P41777; -.
DR   PaxDb; 10116-ENSRNOP00000025788; -.
DR   GeneID; 64896; -.
DR   KEGG; rno:64896; -.
DR   AGR; RGD:621578; -.
DR   CTD; 9221; -.
DR   RGD; 621578; Nolc1.
DR   VEuPathDB; HostDB:ENSRNOG00000018704; -.
DR   eggNOG; KOG2992; Eukaryota.
DR   InParanoid; P41777; -.
DR   OrthoDB; 318182at2759; -.
DR   PhylomeDB; P41777; -.
DR   TreeFam; TF341730; -.
DR   PRO; PR:P41777; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000018704; Expressed in ovary and 20 other cell types or tissues.
DR   GO; GO:0031428; C:box C/D methylation guide snoRNP complex; IDA:RGD.
DR   GO; GO:0031429; C:box H/ACA snoRNP complex; IDA:RGD.
DR   GO; GO:0015030; C:Cajal body; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0062064; F:box C/D methylation guide snoRNP complex binding; IDA:UniProtKB.
DR   GO; GO:0034512; F:box C/D sno(s)RNA binding; IDA:RGD.
DR   GO; GO:0034513; F:box H/ACA snoRNA binding; IDA:RGD.
DR   GO; GO:0062065; F:box H/ACA snoRNP complex binding; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0140678; F:molecular function inhibitor activity; ISO:RGD.
DR   GO; GO:0008139; F:nuclear localization sequence binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0001093; F:TFIIB-class transcription factor binding; IDA:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0033979; P:box H/ACA sno(s)RNA metabolic process; IGI:RGD.
DR   GO; GO:0014032; P:neural crest cell development; ISS:UniProtKB.
DR   GO; GO:0014029; P:neural crest formation; ISS:UniProtKB.
DR   GO; GO:0007000; P:nucleolus organization; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IGI:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0042306; P:regulation of protein import into nucleus; IDA:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0006417; P:regulation of translation; ISS:UniProtKB.
DR   InterPro; IPR006594; LisH.
DR   InterPro; IPR039191; Nopp140-like.
DR   InterPro; IPR007718; Srp40_C.
DR   PANTHER; PTHR23216; NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; 1.
DR   PANTHER; PTHR23216:SF1; NUCLEOLAR AND COILED-BODY PHOSPHOPROTEIN 1; 1.
DR   Pfam; PF05022; SRP40_C; 1.
DR   PROSITE; PS50896; LISH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cytoplasm; Direct protein sequencing;
KW   GTP-binding; Isopeptide bond; Methylation; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN           1..704
FT                   /note="Nucleolar and coiled-body phosphoprotein 1"
FT                   /id="PRO_0000096943"
FT   DOMAIN          10..42
FT                   /note="LisH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00126"
FT   REPEAT          84..95
FT                   /note="Acidic serine cluster 1"
FT   REPEAT          127..138
FT                   /note="Acidic serine cluster 2"
FT   REPEAT          170..181
FT                   /note="Acidic serine cluster 3"
FT   REPEAT          231..242
FT                   /note="Acidic serine cluster 4"
FT   REPEAT          274..285
FT                   /note="Acidic serine cluster 5"
FT   REPEAT          335..346
FT                   /note="Acidic serine cluster 6"
FT   REPEAT          373..384
FT                   /note="Acidic serine cluster 7"
FT   REPEAT          434..445
FT                   /note="Acidic serine cluster 8"
FT   REPEAT          479..490
FT                   /note="Acidic serine cluster 9"
FT   REPEAT          524..535
FT                   /note="Acidic serine cluster 10"
FT   REPEAT          559..570
FT                   /note="Acidic serine cluster 11"
FT   REGION          65..638
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          84..570
FT                   /note="11 X 12 AA approximate repeats of an acidic serine
FT                   cluster"
FT   COMPBIAS        221..235
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        303..336
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        430..451
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        563..579
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        588..602
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..638
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         33
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         88
FT                   /note="Diphosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q5C9"
FT   MOD_RES         88
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q5C9"
FT   MOD_RES         91
FT                   /note="Diphosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q5C9"
FT   MOD_RES         91
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         424
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         567
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         587
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         596
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q5C9"
FT   MOD_RES         612
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         615
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         668
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         688
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         691
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   MOD_RES         703
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        67
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        76
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        189
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        200
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        352
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        357
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        399
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        405
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        410
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        449
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        461
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        510
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        584
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        609
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        618
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        652
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        668
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   CROSSLNK        700
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14978"
FT   VARIANT         150
FT                   /note="Missing (in Nopp140b)"
FT   CONFLICT        141
FT                   /note="E -> K (in Ref. 1; AAA41718/AAA41719)"
SQ   SEQUENCE   704 AA;  73564 MW;  0A911BF1C15E9DBC CRC64;
     MADTGLRRVV PSDLYPLVLG FLRDNQLSEV ASKFAKATGA TQQDANASSL LDIYSFWLKS
     TKAPKVKLQS NGPVAKKAKK ETSSSDSSED SSEEEDKAQV PTQKAAAPAK RASLPQHAGK
     AAAKASESSS SEESSEEEEE EDKKKKPVQQ KAVKPQAKAV RPPPKKAESS ESESDSSSED
     EAPQTQKPKA AATAAKAPTK AQTKAPAKPG PPAKAQPKAA NGKAGSSSSS SSSSSSDDSE
     EEKKAAAPLK KTAPKKQVVA KAPVKVTAAP TQKSSSSEDS SSEEEEEQKK PMKKKAGPYS
     SVPPPSVSLS KKSVGAQSPK KAAAQTQPAD SSADSSEESD SSSEEEKKTP AKTVVSKTPA
     KPAPVKKKAE SSSDSSDSDS SEDEAPAKPV SATKSPLSKP AVTPKPPAAK AVATPKQPAG
     SGQKPQSRKA DSSSSEEESS SSEEEATKKS VTTPKARVTA KAAPSLPAKQ APRAGGDSSS
     DSESSSSEEE KKTPPKPPAK KKAAGAAVPK PTPVKKAAAE SSSSSSSSED SSEEEKKKPK
     SKATPKPQAG KANGVPASQN GKAGKESEEE EEDTEQNKKA AGTKPGSGKK RKHNETADEA
     ATPQSKKVKL QTPNTFPKRK KGEKRASSPF RRVREEEIEV DSRVADNSFD AKRGAAGDWG
     ERANQVLKFT KGKSFRHEKT KKKRGSYRGG SISVQVNSVK FDSE
//
